Dexmedetomidine

Half-Life (t½)
IV: 2h · IN: 2h
Formula
C13H16N2
Molecular Weight
200.28 g/mol
PubChem CID
5311068
Aliases
Precedex

Pharmacological Mechanism

Selective α2-adrenergic agonist — sedation without respiratory depression (preserves arousability). ICU sedation alternative to benzodiazepines reduces delirium incidence; procedural sedation. Bradycardia + hypotension (especially with bolus loading).

Half-Life & Elimination Curve (IV: 2h · IN: 2h)

100%50%25%12.5%0%0h0×t½2h1×t½4h2×t½6h3×t½8h4×t½10h5×t½0×t½ (0h): 100% remaining (~0.00778 µg/L)1×t½ (2h): 50% remaining (~0.00389 µg/L)2×t½ (4h): 25% remaining (~0.00194 µg/L)3×t½ (6h): 12.5% remaining (~0.000972 µg/L)4×t½ (8h): 6.3% remaining (~0.000486 µg/L)5×t½ (10h): 3.1% remaining (~0.000243 µg/L)
Elimination (IV)Effect Site (ke0)
  • 0×t½0h100% (0.00778 µg/L)
  • 1×t½2h50% (0.00389 µg/L)
  • 2×t½4h25% (0.00194 µg/L)
  • 3×t½6h12.5% (0.000972 µg/L)
  • 4×t½8h6.3% (0.000486 µg/L)
  • 5×t½10h3.1% (0.000243 µg/L)
Elimination t½2h (IV)
Rate Constant (ke)0.347 h⁻¹
Est. Peak (Cmax)0.00778 µg/L
Clearance (CL)31.2 L/h
97% Washout (5×t½)10h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References